-
EP2462136
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2462136
| EP2462136 - PHENYL ETHYNYL DERIVATIVES AS HEPATITIS C VIRUS INHIBITORS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 01.05.2015 Database last updated on 19.10.2024 | Most recent event Tooltip | 01.05.2015 | Application deemed to be withdrawn | published on 03.06.2015 [2015/23] | Applicant(s) | For all designated states Janssen Sciences Ireland UC Eastgate Village, Eastgate Little Island, County Cork / IE | [2015/12] |
| Former [2012/24] | For all designated states Janssen R&D Ireland Eastgate Village Eastgate, Little Island, County Cork / IE | Inventor(s) | 01 /
MC GOWAN, David De Biolleylaan 80 Brussel 1150 / BE | 02 /
DEMIN, Samuël, Dominique Kraanstraat 2 B201 B-2800 Mechelen / BE | 03 /
LAST, Stefaan, Julien Crauwelshoeve 59 B-2547 Lint / BE | 04 /
VANDYCK, Koen Deurnestraat 74 B-3583 Paal-Beringen / BE | 05 /
RABOISSON, Pierre, Jean-Marie, Bernard Rue Jolie 3 B-1331 Rosieres / BE | [2012/24] | Representative(s) | van Wanrooij, Eva Johnson & Johnson Patent Law Department Turnhoutseweg 30 2340 Beerse / BE | [N/P] |
| Former [2012/24] | van Wanrooij, Eva Tibotec-Virco Virology BVBA J&J Patent Law Department Turnhoutseweg 30 2340 Beerse / BE | Application number, filing date | 10740234.9 | 06.08.2010 | WO2010EP61493 | Priority number, date | EP20090167438 | 07.08.2009 Original published format: EP 09167438 | [2012/24] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2011015657 | Date: | 10.02.2011 | Language: | EN | [2011/06] | Type: | A1 Application with search report | No.: | EP2462136 | Date: | 13.06.2012 | Language: | EN | The application published by WIPO in one of the EPO official languages on 10.02.2011 takes the place of the publication of the European patent application. | [2012/24] | Search report(s) | International search report - published on: | EP | 10.02.2011 | Classification | IPC: | C07D403/14, C07D401/14, C07D403/04, C07D407/14, A61P31/14, A61K31/4178, A61K31/4406 | [2012/24] | CPC: |
C07D403/14 (EP,US);
A61P31/14 (EP);
C07D403/04 (EP,US);
C07D405/14 (EP,US);
C07D413/14 (EP,US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2012/24] | Title | German: | PHENYLETHYNYLDERIVATE ALS HEMMER DES HEPATITIS-C-VIRUS | [2012/24] | English: | PHENYL ETHYNYL DERIVATIVES AS HEPATITIS C VIRUS INHIBITORS | [2012/24] | French: | DÉRIVÉS DE PHÉNYLÉTHYNYLE EN TANT QU'INHIBITEURS DU VIRUS DE L'HÉPATITE C | [2012/24] | Entry into regional phase | 07.03.2012 | National basic fee paid | 07.03.2012 | Designation fee(s) paid | 07.03.2012 | Examination fee paid | Examination procedure | 07.03.2012 | Examination requested [2012/24] | 21.09.2012 | Amendment by applicant (claims and/or description) | 10.06.2014 | Despatch of a communication from the examining division (Time limit: M06) | 23.12.2014 | Application deemed to be withdrawn, date of legal effect [2015/23] | 23.01.2015 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2015/23] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 10.06.2014 | Fees paid | Renewal fee | 31.08.2012 | Renewal fee patent year 03 | 02.09.2013 | Renewal fee patent year 04 | 01.09.2014 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [IDP]WO2010065668 (PRESIDIO PHARMACEUTICALS INC [US], et al) [IDP] 1-9 * claims 1, 24, 104 * * compounds 99, 104, 105, 110, 112, 123, 128 *; | [AD]WO2008021927 (SQUIBB BRISTOL MYERS CO [US], et al) [AD] 1-9 * claim 1 * * page 1, lines 7-10 *; | [AD]WO2008048589 (XTL BIOPHARMACEUTICALS LTD [US], et al) [AD] 1-9 * claims 1,10 * | Examination | - PAOLA CIAPETTI AND BRUNO GIETHLEN ED - CAMILLE GEORGES WERMUTH, Chapter 15 - Molecular Variations Based on Isosteric Replacements, THE PRACTICE OF MEDICINAL CHEMISTRY (THIRD EDITION), ELSEVIER, NL, PAGE(S) 290 - 342, (20080101), ISBN 978-0-12-374194-3, XP009142466 DOI: http://dx.doi.org/10.1016/B978-0-12-374194-3.00015-9 | by applicant | WO2006133326 | WO2008021927 | WO2008021928 | WO2008048589 | WO2010065668 | EP0013420 | - LOHMANN ET AL., SCIENCE, (1999), vol. 285, pages 110 - 113 | - KRIEGER ET AL., JOURNAL OF VIROLOGY, (2001), vol. 75, pages 4614 - 4624 |